MD talks gift ban, CME measures

Maryland lawmakers are weighing a conflict-of-interest bill that impacts commercially supported CME.
HB 818 would limit industry payments for certified CME programs to seminars that feature more than one presenter. At a hearing, Julie Gottlieb, associate dean of policy coordination for John Hopkins Medical School, asked for this provision to be modified, since CME events can feature a single presenter.
Also, language barring promotion of specific Rx products and marketing activities within CME programs could be interpreted so broadly as to eliminate the ability of HCPs to say that a class of drugs is recommended, Gottlieb warned lawmakers.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.